Elevate Health vs Oak Longevity: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

53 providers verified independently·Independent researchHow we rank →

Oak Longevity beats Elevate Health overall, scoring 7.5/10 vs 7.2/10. Oak Longevity is more affordable at $133/mo vs $233/mo. Choose Elevate Health for users who want financing options and free lab work with thei. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.

A side-by-side look at Elevate Health and Oak Longevity to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for

Elevate Health

#44 of 53
7.2/10

Affordable compounded GLP-1 provider with financing options and complimentary lab work for qualifying patients.

Visit Elevate Health
Higher Rated

Oak Longevity

#25 of 53
7.5/10

Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing, patients pay each month manually rather than auto-renew.

Visit Oak Longevity
FeatureElevate HealthOak Longevity
Our Score7.2/107.5/10
Starting Price$233/mo$133/mo
Medication TypeBothBoth
Insurance AcceptedNoNo
Best ForUsers who want financing options and free lab work with their GLP-1 programBudget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin)
Watch out forPromo-dependent pricing, standard tirzepatide is $449/mo without discount, nearly double the promo priceBrand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct
Ranking#44#25
Get startedVisit Elevate HealthVisit Oak Longevity

Pros & Cons Compared

Elevate Health

Pros

  • +Oral semaglutide from $114/mo, one of the lowest prices for any form of semaglutide in the market
  • +Free blood work included with all GLP-1 programs for baseline health assessment and monitoring
  • +Buy-now-pay-later financing via Affirm, Klarna, and Afterpay, removes the upfront cost barrier
  • +Medications sourced from FDA-registered 503B outsourcing facilities, stricter oversight than standard compounding

Cons

  • Promo-dependent pricing, standard tirzepatide is $449/mo without discount, nearly double the promo price
  • Select state availability only, not available nationwide
  • Trustpilot rating flagged for potential review solicitation, verify independently

Oak Longevity

Pros

  • +$133/mo for compounded semaglutide is among the cheapest entries on the market, Sesame Care ($99) is lower, but Oak undercuts most mid-tier platforms
  • +No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
  • +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
  • +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
  • +Money-back guarantee if not approved by physician, useful safety net for borderline-eligibility patients
  • +Free shipping and free health coaching included in every program

Cons

  • Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct
  • No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
  • The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
  • The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
  • Newer brand without disclosed company history, founding date, or executive team on landing pages
  • Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits

Our Verdict

Oak Longevity edges out Elevate Health with a score of 7.5/10 vs 7.2/10. If budget is your priority, Oak Longevity starts at $133/mo compared to Elevate Health's $233/mo. Choose Elevate Health if you want: users who want financing options and free lab work with their glp-1 program. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).

Still undecided? Editor's Featured Pick

TrimRx

$149/mo · 7.8/10 · Compounded

If neither Elevate Health nor Oak Longevity feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.

Try Elevate Health

Starting at $233/mo

Visit Elevate Health

Try Oak Longevity

Starting at $133/mo

Visit Oak Longevity

Related comparisons

Other matchups readers comparing Elevate Health or Oak Longevity tend to look at next.

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Featured Partners

Four affiliate partners we feature, we may earn a commission.

TrimRx

7.8/10
$149/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Embody

7.3/10
$149/mo·Compounded

SkinnyRx

7.3/10
$199/mo·Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.